NEW YORK (GenomeWeb) – MDxHealth announced today that it has been awarded a US General Services Administration contract to supply its ConfirmMDx prostate cancer test to the Department of Veterans Affairs.

According to the company, the five-year contract provides coverage of ConfirmMDx testing at the Medicare rate for veterans with the VA health system beginning February 1. Additional terms were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.